FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39425911000001102: Selumetinib hydrogen sulfate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Apr 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2045371000001114 Selumetinib hydrogen sulfate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2045381000001111 Selumetinib hydrogen sulfate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selumetinib hydrogen sulfate Is a Substance with mitogen-activated protein kinase kinase inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Selumetinib 10mg capsules Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier
Selumetinib 25mg capsules Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier
Selumetinib 10mg capsules 60 capsule Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) 60 capsule Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier
Koselugo 25mg capsules (AstraZeneca UK Ltd) Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier
Selumetinib 25mg capsules 60 capsule Has specific active ingredient True Selumetinib hydrogen sulfate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start